Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: '584 Final Rejection now posted in IFW. Claims 29 - 54 rejected. eom

Re: "We are treading on risky ground, if the 749, and the 148 get shot down like the 584, then you can expect a great loss of Share value."

And just to make things more interesting, our upcoming Q report will likely show a loss on only 2 license sales and increased costs related to new endeavors.

This is a long term investment at best. Slow but hopefully sure. We are unlikely to see the miracles many posters have hyped about.



Share
New Message
Please login to post a reply